The lack of prospective randomized clinical trials for most management topics in
differentiated thyroid cancer forces us to make management recommendations based on …

Background The recently published 2015 American Thyroid Association guidelines
recognize lobectomy as a viable alternative for low-risk cancers and advise more …

Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Thyroid cancer is rapidly increasing in incidence, but the mortality rate remains flat. Debate
has arisen over the need to detect or treat most thyroid cancers early, given their favorable …

Background Both radioactive iodine (RAI) and external beam radiation therapy (EBRT) offer
important clinical benefits in properly selected patients with differentiated thyroid cancer …

The procedure guideline for radioiodine therapy of differentiated thyroid cancer (version 4)
was developed in the consensus of a representative expert group. This fulfils the level S1 …

Management recommendations for differentiated thyroid cancer are evolving. Total
thyroidectomy is the backbone of curative-intent therapy, with radioiodine ablation (RAI) of …

Background: The American Thyroid Association (ATA), the European Association of Nuclear
Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and …

Context: Little is known about practice patterns in thyroid cancer, a cancer that is increasing
in incidence. Objective: We sought to identify aspects of thyroid cancer management that …

Recently, there have been important advances in the diagnosis of thyroid cancer as well as
in our understanding of the biologic nature of thyroid cancer. Most patients with thyroid …